Teleflex Incorporated (NYSE:TFX) Receives Average Rating of "Hold" from Brokerages

Key Points

• Teleflex (NYSE: TFX) received a consensus rating of "Hold" from nine brokerages, with one sell, five hold, and three buy ratings. The average 1-year price target among analysts is about $142.86.
• The company recently beat Q1 earnings and revenue estimates, reporting EPS of $1.39 versus $1.21 expected and revenue of $548.3 million versus $536.9 million expected. Revenue also rose 32.3% year over year.
• Despite the quarterly beat, Teleflex’s FY2026 EPS guidance of $6.25 to $6.55 came in below market expectations, which may temper investor enthusiasm. The company also pays a quarterly dividend of $0.34, equal to a 1.0% annual yield.

Teleflex Incorporated (NYSE:TFX - Get Free Report) has been assigned a consensus rating of "Hold" from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $142.8571.

Several equities analysts have recently weighed in on TFX shares. Bank of America raised Teleflex from an "underperform" rating to a "neutral" rating and set a $135.00 target price on the stock in a research report on Monday, April 13th. Weiss Ratings reissued a "sell (d)" rating on shares of Teleflex in a research report on Friday, March 27th. Zacks Research raised Teleflex from a "strong sell" rating to a "hold" rating in a research report on Tuesday, April 28th. Needham & Company LLC upped their price objective on Teleflex from $138.00 to $147.00 and gave the company a "buy" rating in a research report on Thursday, February 26th. Finally, Wells Fargo & Company upped their price objective on Teleflex from $130.00 to $138.00 and gave the company an "equal weight" rating in a research report on Friday.

Hedge Funds Weigh In On Teleflex

Several hedge funds have recently bought and sold shares of the business. Janus Henderson Group PLC grew its position in Teleflex by 2.0% in the 4th quarter. Janus Henderson Group PLC now owns 4,246,112 shares of the medical technology company's stock valued at $518,196,000 after acquiring an additional 84,754 shares during the last quarter. AQR Capital Management LLC grew its position in Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock valued at $287,603,000 after acquiring an additional 1,956,811 shares during the last quarter. State Street Corp grew its position in Teleflex by 1.5% in the 4th quarter. State Street Corp now owns 1,478,776 shares of the medical technology company's stock valued at $180,470,000 after acquiring an additional 22,111 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Teleflex by 0.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company's stock valued at $152,630,000 after acquiring an additional 5,051 shares during the last quarter. Finally, Cooke & Bieler LP grew its position in Teleflex by 1.2% in the 3rd quarter. Cooke & Bieler LP now owns 1,220,637 shares of the medical technology company's stock valued at $149,357,000 after acquiring an additional 14,673 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Performance

NYSE TFX opened at $133.17 on Friday. The company has a market cap of $5.89 billion, a P/E ratio of -5.84, a P/E/G ratio of 0.95 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.01 and a current ratio of 2.55. The business's 50 day moving average price is $119.44 and its 200-day moving average price is $116.73. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $139.67.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company's revenue for the quarter was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts predict that Teleflex will post 6.75 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Friday, March 6th. Teleflex's dividend payout ratio is -6.62%.

More Teleflex News

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Teleflex beat Q1 estimates, reporting adjusted EPS of $1.39 versus $1.21 expected and revenue of $548.3 million versus $536.9 million expected, which signals solid execution in the quarter. Article Title
• Positive Sentiment: The company maintained its full-year 2026 outlook and announced plans for a buyback, which can support investor confidence and share price performance. Article Title
• Positive Sentiment: Wells Fargo raised its price target on TFX from $130 to $138, implying modest upside from current levels and suggesting improved analyst sentiment. Article Title
• Neutral Sentiment: Management’s earnings call commentary was described as balanced, with growth offset by margin strain, indicating the business is still navigating profitability pressure even after the earnings beat. Article Title
• Negative Sentiment: Teleflex’s updated FY2026 EPS guidance of $6.25 to $6.55 came in below the market’s expectation of about $6.73, which could limit enthusiasm despite the quarterly beat. Article Title

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.